ATEC News and Press, Alphatec Holdings Inc. From 10/11/22

Innovation designed to expand lateral adoption and improve patient outcomes Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company will introduce at the 2022 NA...

Total revenue of $89 to $90 million Total revenue growth of 42% to 43%, including organic revenue growth of 51% to 53% Full-year 2022 total revenue growth now expected to approximate 40% Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutio...

Company will showcase lateral sophistication and information-based clinical influence Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company’s comprehensiv...

The following slide deck was published by Alphatec Holdings, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Alphatec Holdings, Inc. 2022 Q2 - Results - Earnings Call Presentation

Alphatec press release ( NASDAQ: ATEC ): Q2 GAAP EPS of -$0.36 misses by $0.05 . Revenue of $84M (+34.9% Y/Y) beats by $5.91M . Organic revenue growth of 30% EOS imaging generates revenue of $12 million Company increases full-year revenue guidance to $3...

Total revenue grows 35% to $84 million, including organic revenue growth of 30% EOS imaging generates revenue of $12 million Company increases full-year revenue guidance to $325 million, reflecting 34% growth Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of inno...

Alphatec has regained commercial traction with its spine business. Strong growth is accompanied by poor margins and lack of operating leverage, despite solid sales growth. Given the cash burn and limited financing options, I am still very cautious here. In July of last y...

Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2022 financial results on August 4, 2022, after the market close. The Company will host a live webcas...

Alphatec has weakened against the benchmark and sector peers in FY22 and continues to display forward-looking downside. A series of operating and FCF losses have put the company out of favour with investors, who are searching for profitability and high quality instead. We've price...

Aurora Spine has three products, DEXA, SILO, and ZIP that have been met with early strong market interest evidenced by sequential quarterly revenue growth exceeding 20% over the last year. DEXA is the first commercially available technology that provides customized devices matching an...